Norihiro Kaneko < Norihiro Nishimoto < Norihiro Okada

Facettes : Author.f AffPays.f Mesh.f AffRegion.f AffVille.f AffOrg.f

List of bibliographic references

Number of relevant bibliographic references: 54.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000124 (2020)	Yoshikazu Nakaoka ; Mitsuaki Isobe ; Yoshiya Tanaka ; Tomonori Ishii ; Seido Ooka ; Hiroaki Niiro [Japon] ; Naoto Tamura ; Shogo Banno ; Hajime Yoshifuji [Japon] ; Yasushi Sakata ; Atsushi Kawakami ; Tatsuya Atsumi ; Shunsuke Furuta ; Hitoshi Kohsaka ; Katsuya Suzuki ; Ryoki Hara ; Yasuhiro Maejima ; Hiroshi Tsukamoto ; Yoshinari Takasaki ; Katsuhisa Yamashita ; Norihiro Okada ; Shinji Yamakido ; Syuji Takei ; Shumpei Yokota [Japon] ; Norihiro Nishimoto [Japon]	Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.
000204 (2020)	Miho Murakami [Japon] ; Takeshi Johkoh [Japon] ; Seiji Hayashi [Japon] ; Shiro Ohshima [Japon] ; Masao Mizuki [Japon] ; Shin-Ichi Nakatsuka [Japon] ; Minako Tomobe ; Kazuyuki Kuroyanagi ; Ayako Nakasone ; Norihiro Nishimoto [Japon]	Clinicopathologic characteristics of 342 patients with multicentric Castleman disease in Japan.
000844 (2018)	Yoshikazu Nakaoka [Japon] ; Mitsuaki Isobe [Japon] ; Syuji Takei [Japon] ; Yoshiya Tanaka [Japon] ; Tomonori Ishii [Japon] ; Shumpei Yokota [Japon] ; Akira Nomura [Japon] ; Seitaro Yoshida [Japon] ; Norihiro Nishimoto [Japon]	Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).
000B71 (2017)	Naoki Ishiguro [Japon] ; Tatsuya Atsumi [Japon] ; Masayoshi Harigai [Japon] ; Tsuneyo Mimori [Japon] ; Norihiro Nishimoto [Japon] ; Takayuki Sumida [Japon] ; Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Ayako Nakasone [Japon] ; Nobuhiro Takagi ; Hisashi Yamanaka [Japon]	Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study.
000F59 (2015)	Miho Murakami [Japon] ; Norihiro Nishimoto [Japon]	[IL-6 inhibitors prevent bone loss and cartilage degeneration in rheumatoid arthritis].
001073 (2015)	Atsushi Ogata ; Koichi Amano ; Hiroaki Dobashi ; Masayuki Inoo ; Tomonori Ishii ; Tsuyoshi Kasama ; Shinichi Kawai ; Atsushi Kawakami ; Tatsuya Koike ; Hisaaki Miyahara ; Toshiaki Miyamoto ; Yasuhiko Munakata ; Akira Murasawa ; Norihiro Nishimoto ; Noriyoshi Ogawa ; Tomohiro Ojima ; Hajime Sano ; Kenrin Shi ; Eisuke Shono ; Eiichi Suematsu ; Hiroki Takahashi ; Yoshiya Tanaka ; Hiroshi Tsukamoto ; Akira Nomura	Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study.
001219 (2014)	Norihiro Nishimoto	[Programs for continuing medical education: a session; 8. Pharmacotherapy of rheumatoid arthritis--interleukin-6 blocker made in Japan].
001295 (2014)	Norihiro Nishimoto [Japon] ; Koichi Amano ; Yasuhiko Hirabayashi ; Takahiko Horiuchi ; Tomonori Ishii ; Mitsuhiro Iwahashi ; Masahiro Iwamoto ; Hitoshi Kohsaka ; Masakazu Kondo ; Tsukasa Matsubara ; Toshihide Mimura ; Hisaaki Miyahara ; Shuji Ohta ; Yukihiko Saeki ; Kazuyoshi Saito ; Hajime Sano ; Kiyoshi Takasugi ; Tsutomu Takeuchi ; Shigeto Tohma ; Tomomi Tsuru ; Yukitaka Ueki ; Jiro Yamana ; Jun Hashimoto ; Takaji Matsutani ; Miho Murakami ; Nobuhiro Takagi	Retreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study.
001328 (2014)	Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu Kishimoto	Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan.
001348 (2014)	Tomomi Tsuru [Japon] ; Kimio Terao ; Miho Murakami ; Takaji Matsutani ; Midori Suzaki ; Toshiaki Amamoto ; Hitoshi Nakashima ; Azusa Akiyama ; Norihiro Nishimoto	Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab.
001380 (2014)	Norihiro Nishimoto [Japon] ; Koichi Amano ; Yasuhiko Hirabayashi ; Takahiko Horiuchi ; Tomonori Ishii ; Mitsuhiro Iwahashi ; Masahiro Iwamoto ; Hitoshi Kohsaka ; Masakazu Kondo ; Tsukasa Matsubara ; Toshihide Mimura ; Hisaaki Miyahara ; Shuji Ohta ; Yukihiko Saeki ; Kazuyoshi Saito ; Hajime Sano ; Kiyoshi Takasugi ; Tsutomu Takeuchi ; Shigeto Tohma ; Tomomi Tsuru ; Yukitaka Ueki ; Jiro Yamana ; Jun Hashimoto ; Takaji Matsutani ; Miho Murakami ; Nobuhiro Takagi	Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study.
001474 (2013)	Milan Fiala [États-Unis] ; Mathew T. Mizwicki ; Rachel Weitzman ; Larry Magpantay ; Norihiro Nishimoto	Tocilizumab infusion therapy normalizes inflammation in sporadic ALS patients.
001559 (2013)	Shumpei Yokota ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu Kishimoto	Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan.
001605 (2013)	Josef S. Smolen [Autriche] ; Monika M. Schoels ; Norihiro Nishimoto ; Ferdinand C. Breedveld ; Gerd R. Burmester ; Maxime Dougados ; Paul Emery ; Gianfranco Ferraccioli ; Cem Gabay ; Allan Gibofsky ; Juan Jesus Gomez-Reino ; Graeme Jones ; Tore K. Kvien ; Miho Murakami ; Neil Betteridge ; Clifton O. Bingham ; Vivian Bykerk ; Ernest H. Choy ; Bernard Combe ; Maurizio Cutolo ; Winfried Graninger ; Angel Lanas ; Emilio Martin-Mola ; Carlomaurizio Montecucco ; Mikkel Ostergaard ; Karel Pavelka ; Andrea Rubbert-Roth ; Naveed Sattar ; Marieke Scholte-Voshaar ; Yoshiya Tanaka ; Michael Trauner ; Gabriele Valentini ; Kevin L. Winthrop ; Maarten De Wit ; Désirée Van Der Heijde	Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions.
001619 (2013)	Monika M. Schoels [Autriche] ; Désirée Van Der Heijde ; Ferdinand C. Breedveld ; Gerd R. Burmester ; Maxime Dougados ; Paul Emery ; Gianfranco Ferraccioli ; Cem Gabay ; Allan Gibofsky ; Juan Jesus Gomez-Reino ; Graeme Jones ; Tore K. Kvien ; Miho Murakami ; Miho M. Murikama ; Norihiro Nishimoto ; Josef S. Smolen	Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement.
001669 (2012)	Miho Murakami ; Minako Tomiita [Japon] ; Norihiro Nishimoto	Tocilizumab in the treatment of systemic juvenile idiopathic arthritis.
001710 (2012)	Makoto Hirao [Japon] ; Naomi Yamasaki ; Hiroki Oze ; Kosuke Ebina ; Akihide Nampei ; Yoshitaka Kawato ; Kenrin Shi ; Hideki Yoshikawa ; Norihiro Nishimoto ; Jun Hashimoto	Serum level of oxidative stress marker is dramatically low in patients with rheumatoid arthritis treated with tocilizumab.
001713 (2012)	Tomoyuki Imagawa [Japon] ; Shumpei Yokota ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Hiroyuki Imanaka ; Yasuhito Nerome ; Naomi Iwata ; Takuji Murata ; Mari Miyoshi ; Norihiro Nishimoto ; Tadamitsu Kishimoto	Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis.
001725 (2012)	Shunsuke Mori [Japon] ; Hitoshi Tokuda ; Fumikazu Sakai ; Takeshi Johkoh ; Akio Mimori ; Norihiro Nishimoto ; Sadatomo Tasaka ; Kazuhiro Hatta ; Hidekazu Matsushima ; Shunji Kaise ; Atsushi Kaneko ; Shigeki Makino ; Seiji Minota ; Takashi Yamada ; Shinobu Akagawa ; Atsuyuki Kurashima	Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan.
001758 (2012)	Daisuke Hoshi [Japon] ; Ayako Nakajima ; Eisuke Inoue ; Kumi Shidara ; Eri Sato ; Mariko Kitahama ; Yohei Seto ; Eiichi Tanaka ; Wako Urano ; Naomi Ichikawa ; Yumi Koseki ; Shigeki Momohara ; Astuo Taniguchi ; Norihiro Nishimoto ; Hisashi Yamanaka	Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab.
001842 (2011)	Miho Murakami [Japon] ; Norihiro Nishimoto	The value of blocking IL-6 outside of rheumatoid arthritis: current perspective.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Norihiro Nishimoto" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "Norihiro Nishimoto" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Norihiro Nishimoto
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021